Huntington National Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Sell
5,602
-214
-4% -$70.3K 0.01% 427
2025
Q4
$2.04M Sell
5,816
-1,288
-18% -$435K 0.01% 352
2025
Q3
$2.3M Sell
7,104
-3,459
-33% -$1.08M 0.01% 331
2025
Q2
$4.11M Sell
10,563
-938
-8% -$377K 0.03% 262
2025
Q1
$5M Sell
11,501
-12,576
-52% -$5.05M 0.04% 243
2024
Q4
$8.88M Sell
24,077
-8,415
-26% -$3.52M 0.06% 199
2024
Q3
$16.9M Sell
32,492
-4,816
-13% -$2.57M 0.12% 147
2024
Q2
$20.2M Sell
37,308
-10,534
-22% -$5.57M 0.16% 129
2024
Q1
$24.8M Sell
47,842
-31,599
-40% -$15.7M 0.2% 116
2023
Q4
$37.5M Sell
79,441
-17,415
-18% -$8.05M 0.34% 76
2023
Q3
$42.2M Buy
96,856
+2,256
+2% +$1.02M 0.42% 65
2023
Q2
$42M Buy
94,600
+32,578
+53% +$15M 0.39% 67
2023
Q1
$28.5M Buy
62,022
+5,825
+10% +$2.77M 0.28% 98
2022
Q4
$28.8M Buy
56,197
+25,652
+84% +$13M 0.3% 95
2022
Q3
$13.9M Buy
30,545
+11,418
+60% +$5.46M 0.16% 135
2022
Q2
$9.23M Buy
19,127
+78
+0.4% +$38.6K 0.1% 183
2022
Q1
$9.36M Buy
19,049
+372
+2% +$170K 0.09% 188
2021
Q4
$8.66M Buy
18,677
+1,285
+7% +$541K 0.08% 204
2021
Q3
$6.48M Buy
17,392
+8
+0% +$3.04K 0.06% 212
2021
Q2
$6.64M Buy
17,384
+1,338
+8% +$511K 0.07% 210
2021
Q1
$5.76M Buy
16,046
+2,353
+17% +$757K 0.07% 190
2020
Q4
$4.4M Sell
13,693
-1,271
-8% -$390K 0.06% 201
2020
Q3
$4.02M Sell
14,964
-1,454
-9% -$391K 0.06% 194
2020
Q2
$4.32M Sell
16,418
-13,874
-46% -$3.7M 0.07% 188
2020
Q1
$6.88M Sell
30,292
-8,657
-22% -$2.36M 0.13% 147
2019
Q4
$11.8M Sell
38,949
-13,484
-26% -$3.71M 0.18% 130
2019
Q3
$12.6M Sell
52,433
-54,591
-51% -$15M 0.2% 119
2019
Q2
$30.2M Sell
107,024
-24,367
-19% -$6.66M 0.49% 61
2019
Q1
$37.7M Buy
131,391
+10,933
+9% +$3.16M 0.62% 49
2018
Q4
$31.6M Buy
120,458
+29,275
+32% +$8.05M 0.56% 56
2018
Q3
$25M Buy
91,183
+41,672
+84% +$10.8M 0.39% 83
2018
Q2
$11.8M Buy
49,511
+37,627
+317% +$8.71M 0.2% 138
2018
Q1
$2.61M Sell
11,884
-2,491
-17% -$585K 0.04% 258
2017
Q4
$3.23M Sell
14,375
-248
-2% -$52.8K 0.05% 246
2017
Q3
$2.78M Sell
14,623
-327
-2% -$62.2K 0.05% 261
2017
Q2
$2.81M Buy
14,950
+1,116
+8% +$201K 0.05% 255
2017
Q1
$2.29M Sell
13,834
-1,163
-8% -$185K 0.04% 273
2016
Q4
$2.16M Sell
14,997
-3,517
-19% -$471K 0.04% 272
2016
Q3
$2.32M Sell
18,514
-2,506
-12% -$324K 0.04% 260
2016
Q2
$2.76M Buy
21,020
+2,616
+14% +$358K 0.07% 211
2016
Q1
$2.84M Sell
18,404
-3,367
-15% -$450K 0.07% 212
2015
Q4
$3.04M Buy
21,771
+500
+2% +$68.9K 0.08% 209
2015
Q3
$2.98M Buy
21,271
+2,106
+11% +$317K 0.08% 214
2015
Q2
$3.15M Buy
19,165
+761
+4% +$122K 0.08% 209
2015
Q1
$2.84M Buy
18,404
+263
+1% +$37.4K 0.07% 214
2014
Q4
$2.28M Sell
18,141
-2,234
-11% -$276K 0.05% 230
2014
Q3
$2.44M Sell
20,375
-489
-2% -$56.1K 0.05% 327
2014
Q2
$2.25M Buy
20,864
+126
+0.6% +$13K 0.04% 387
2014
Q1
$2.06M Sell
20,738
-630
-3% -$57K 0.04% 427
2013
Q4
$1.97M Sell
21,368
-999
-4% -$88.8K 0.05% 247
2013
Q3
$1.87M Buy
22,367
+318
+1% +$27.3K 0.06% 237
2013
Q2
$1.8M Buy
+22,049
New +$1.65M 0.06% 236

Other funds holding ELV

Huntington National Bank's ELV Position: Q1 2026 in Review

Huntington National Bank reduced its Elevance Health (ELV) stake by 3.7% in Q1 2026, selling an estimated $70.3K and leaving 5,602 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #427.

Huntington National Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.2M in Q3 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Huntington National Bank held 5,602 shares of Elevance Health worth $1.64M as of Q1 2026.
  • Huntington National Bank sold 214 Elevance Health shares in Q1 2026, an estimated $70.3K.
  • Elevance Health made up 0.01% of Huntington National Bank's portfolio in Q1 2026, its #427 holding.
  • Huntington National Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Huntington National Bank's Elevance Health position peaked at $42.2M in Q3 2023.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.